Option chain shows key data for BlackRock Science's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for BlackRock Science.

BlackRock Science (NYSE:BSTZ) Stock, Option Chain

BlackRock Science

BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.

News

Intraday Update

Markets

Movers

Trading Ideas

ABCB

ABEV

ACAM

ACBI

ACCO

ACEL

ACER

ACIW

ACLS

ACRS

ACST

ADOM

AEHR

AGRO

AIMC

AINV

AIRT

ALEX

ALGN

ALGT

ALOT

AMAL

AMKR

AMOT

AMPH

AMRB

AMSC

AMWD

ANIK

ANIX

AOSL

APEN

APLE

APOG

APPN

APYX

AQUA

ARCC

ARCO

ARDC

ARDS

ARKR

AROW

ARPO

ASRV

ATKR

ATRS

AVAL

AVNW

AWSM

AXNX

AZUL

Stocks That Hit 52-Week Lows On Thursday

AACG

AAOI

ABMD

ACGL

ACHC

ACHV

ACIU

ACRE

ACRX

ACTG

ADES

ADMP

ADMS

ADNT

ADPT

ADTN

AEIS

AERI

AEZS

AFGC

AFIN

AFMD

AGFS

AGLE

AGYS

AIMT

AKCA

AKTS

AKTX

ALBO

ALDX

Stocks That Hit 52-Week Lows On Monday

AAON

AAWW

ABTX

ACNB

ADMA

AFYA

AGCO

AGNC

AKRX

ALKS

ALLY

ALRM

ALRS

BlackRock Science and Technology Term Trust Common Shares of Beneficial Interest

BlackRock Science and Technology Trust II

<p>Richmond Mutual Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBI#NASDAQ">RMBI</a>) reported quarterly earnings of $0.25 per share. This is a 31.58 percent increase over earnings of $0.19 per share from the same period last year.</p>


Earnings

RMBI

Richmond Mutual Bancorp Q4 EPS $0.25 Up From $0.19 YoY

<p>Disney Experiences Chairman Josh D'Amaro today announced several appointments for members of his executive team including a newly created role to oversee major events integration, and new heads for Disneyland Resort, Disney Signature Experiences and Shanghai Disney Resort. The announcement comes as Disney Experiences has embarked on ambitious expansion plans for its cruise line business and at theme parks around the world.</p>
<p>"We have a deep bench of globally minded business leaders who bring the versatility needed to step into key roles across our diverse portfolio," said Josh D'Amaro, Chairman, Disney Experiences. "These tenured leaders have extensive technical and operational expertise with strong insight and understanding of the guest experience, and possess qualities that promote innovation, creativity, and results."</p>
<p>Josh D'Amaro announced the following strategic senior executive changes:</p>
<ul>
<li>Ken Potrock, a 30-year Disney veteran will take on the newly created role of President, The Walt Disney Company Major Events Integration. In this role, Potrock will be responsible for developing comprehensive, cross-company plans to maximize the value of large-scale sports, entertainment and tourism events ranging from the 2028 Los Angeles Olympics to the 250th Anniversary of the nation. Potrock joined Disneyland Resort in 2020 and led the successful post-pandemic reopening, and recently secured the approval of DisneylandForward, which unlocks opportunities for expansion and investment in Anaheim for the next 40 years. During his tenure, he also oversaw the opening of Avengers Campus, the reimagining of Pixar Place Hotel, the expansion of the Downtown Disney District, and the continued expansion of Disney California Adventure – including the recent announcement of two new attractions coming to Avengers Campus, and new attractions inspired by Avatar and Coco. Potrock will continue to report to D'Amaro, with accountability to Jimmy Pitaro, Chairman ESPN.</li>
<li>Thomas Mazloum has been appointed the new President of Disneyland Resort. In this role, Mazloum will lead more than 36,000 Cast Members and oversee the operation of two theme parks, three resort hotels, and the Downtown Disney District, and will guide Disneyland Resort through a new era of growth with the recent approval of DisneylandForward. Under Mazloum's recent leadership of Disney Signature Experiences, Disney Cruise Line secured investments and development plans to double its fleet size by 2031. Prior to his time at Disney Cruise Line, Mazloum held various leadership positions at Walt Disney World, overseeing Operations, Resorts, Transportation, ESPN Wide World of Sports, Club 33, Disney Springs and more. Mazloum will continue to report to D'Amaro.</li>
<li>Joe Schott has been appointed President of Disney Signature Experiences (DSE), a division of Disney Experiences that offers family travel and leisure experiences beyond theme parks, including Disney Cruise Line (DCL), Disney Vacation Club, Aulani – a Disney Resort &amp; Spa, Adventures by Disney, Storyliving by Disney and more. Schott's Disney career spans 40 years, and since 2019 he has led Shanghai Disney Resort as President and General Manager. Under his leadership, Shanghai Disneyland expanded to include the successful Zootopia-themed land, new attractions and entertainment, and in development, a third hotel and a new Spider-Man-themed attraction. Prior to his role in Shanghai, Schott led operations at Disneyland Paris and was Executive Managing Director of Walt Disney Attractions Japan at Tokyo Disney Resort. Schott's vast experience in global markets and his extensive knowledge of our international operations will be pivotal as Disney Cruise Line expands its fleet to new destinations worldwide. Schott will now report directly to D'Amaro.</li>
<li>Andrew Bolstein is promoted to President &amp; General Manager of Shanghai Disney Resort. Bolstein was part of the opening leadership team at Shanghai Disney Resort, working hand-in-hand with Imagineers as the park took shape. His 30-year career started at Walt Disney World and included leadership roles in Hong Kong and Tokyo, and nearly 13 years in Shanghai. Bolstein brings deep operational knowledge, passion for the Cast and surrounding community, and strong relationships with key government, business and industry partners. Andrew will report to Jill Estorino, President and Managing Director of Disney Parks International.</li>
</ul>
<p>Disney Experiences has an expansive footprint in the global theme park travel and experience business with 12 parks around the world; Disney Cruise Line, which visits ports in nearly 40 countries and will more than double the size of its current fleet by 2031; and, Disney's industry-leading consumer products division, which brings Disney IP into fans' homes across the globe and is the largest licensor in the world.</p>
<p>Transition to the new roles will begin immediately.</p>


Management

Global

Disney Experiences Announces Leadership Appointments Amid Global Expansion Plans; Ken Potrock Named President Of Major Events Integration, Thomas Mazloum To Lead Disneyland Resort, Joe Schott Heads Disney Signature Experiences, Andrew Bolstein Promoted To Shanghai Disney Resort, Effective Immediately

<p>The DOC will disburse the Awards funding to the Company based on the achievement of various milestones, with each disbursement reimbursing the Company for eligible uses of funds already incurred and paid by the Company. Disbursements are Project-specific and subject to the achievement of various capital expenditure, facility development, production qualification, the receipt of applicable permits and other governmental approvals, and various other conditions.</p>
<p><br />&nbsp;</p>


INFN

On January 16, 2025, Infinera Entered Into Direct Funding Agreement For Up To $93M With US Department Of Commerce  Under CHIPS Act - Filing

<p><strong>Intuitive Surgical Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported financial results for the fourth quarter after the market close on Thursday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/01/g43176400/intuitive-announces-fourth-quarter-earnings">from the quarter.</a></p>
<p><strong>Q4 Earnings:</strong> Intuitive Surgical reported fourth-quarter revenue of $2.41 billion, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $2.25 billion. The robotic-assisted surgery company reported fourth-quarter adjusted earnings of $2.21 per share, beating analyst estimates of $1.79 per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.</p>
<p>Revenue climbed 25% on a year-over-year basis. Worldwide da Vinci procedures increased approximately 18% year-over-year. The company said it&nbsp;placed 493 da Vinci surgical systems in the quarter, versus 415 in the prior year's quarter. Fourth-quarter placements included 174 da Vinci 5 systems. Intuitive Surgical's da Vinci surgical system installed base totaled 9,902 systems as of Dec. 31, up 15% year-over-year. </p>
<p>The company ended the quarter with $8.83 billion in cash, cash equivalents and investments, up $521 million during the quarter.</p>
<p><strong>Outlook:</strong> Intuitive Surgical expects full-year 2025 worldwide da Vinci procedures to increase approximately&nbsp;13%&nbsp;to&nbsp;16%. The company expects gross profit margin to be between&nbsp;67%&nbsp;and&nbsp;68%&nbsp;of net revenue in 2025.</p>
<p>Intuitive shares were down 0.1% after hours at last check, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The stock moved higher last week after the company reported preliminary results ahead of a presentation at the annual JPMorgan Healthcare Conference. The muted response on Thursday is likely due to the preliminary report. </p>
<p>&#8220;We are pleased with customer adoption of da Vinci 5, Ion, and SP during the quarter and full year. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes,&#8221; Intuitive Surgical CEO <strong>Gary Guthart</strong> said in the preliminary release.</p>
<p>Management will further discuss the quarter on a conference call with analysts and investors at 4:30 p.m. ET.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/previews/25/01/43174420/verizon-q4-earnings-preview-company-show-5g-growth-reverse-streak-revenue-misses"><strong>Verizon Q4 Earnings Preview: Will Company Show 5G Growth, Reverse Streak Of Revenue Misses?</strong></a></li>
</ul>
<p><em>Photo: Courtesy of Intuitive Surgical.</em></p>


Health Care

After-Hours Center

ISRG

Intuitive Surgical Q4 Earnings: Revenue Beat, EPS Beat, Da Vinci Procedures Jump 18% And More

<p><strong>CSX</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) announced its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>CSX missed estimated earnings by 0.0%, reporting an EPS of $0.42 versus an estimate of $0.42.</p>
<p>Revenue was down $140.00 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company missed on EPS by $0.02 in the previous quarter, leading to a 7.000000000000001% drop share price change the next day.</p>
<p>Here's a look at CSX's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.48</td>
<td>0.48</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.46</td>
<td>0.49</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>3.67B</td>
<td>3.70B</td>
<td>3.66B</td>
<td>3.63B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>3.62B</td>
<td>3.70B</td>
<td>3.68B</td>
<td>3.68B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for CSX <a href="https://www.benzinga.com/quote/CSX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: CSX Q4

<p>The Q4 earnings report for <strong>Intuitive Surgical</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) was released on Thursday, January 23, 2025 at 04:04 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Intuitive Surgical beat estimated earnings by 23.0%, reporting an EPS of $2.21 versus an estimate of $1.79.</p>
<p>Revenue was up $485.70 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company beat on EPS by $0.21 in the last quarter, resulting in a 10.0% increase share price change the following day.</p>
<p>Here's a look at Intuitive Surgical's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.63</td>
<td>1.54</td>
<td>1.41</td>
<td>1.48</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.84</td>
<td>1.78</td>
<td>1.50</td>
<td>1.60</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.00B</td>
<td>1.97B</td>
<td>1.87B</td>
<td>1.87B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.04B</td>
<td>2.01B</td>
<td>1.89B</td>
<td>1.93B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Intuitive Surgical <a href="https://www.benzinga.com/quote/ISRG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into Intuitive Surgical Q4 Earnings

<p><strong>Texas Instruments</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) just disclosed its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Texas Instruments beat estimated earnings by 8.0%, reporting an EPS of $1.3 versus an estimate of $1.2.</p>
<p>Revenue was down $70.00 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.09 in the previous quarter, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at Texas Instruments's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.38</td>
<td>1.17</td>
<td>1.07</td>
<td>1.46</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.47</td>
<td>1.22</td>
<td>1.20</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>4.12B</td>
<td>3.82B</td>
<td>3.61B</td>
<td>4.12B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>4.15B</td>
<td>3.82B</td>
<td>3.66B</td>
<td>4.08B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Texas Instruments management provided guidance for Q1 2025, expecting earnings between $0.94 and $1.16 per share.</p>
<p>To track all earnings releases for Texas Instruments <a href="https://www.benzinga.com/quote/TXN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Texas Instruments Q4

<p>The earnings results for <strong>Business First Bancshares</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) for Q4 were made public on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Business First Bancshares beat estimated earnings by 35.0%, reporting an EPS of $0.66 versus an estimate of $0.49.</p>
<p>Revenue was up $17.41 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company beat on EPS by $0.11, resulting in a 4.0% increase change in the share price the following day.</p>
<p>Here's a look at Business First Bancshares's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.57</td>
<td>0.51</td>
<td>0.57</td>
<td>0.60</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.64</td>
<td>0.50</td>
<td>0.66</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>65.32M</td>
<td>62.96M</td>
<td>62.22M</td>
<td>62.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>66.90M</td>
<td>66.19M</td>
<td>60.92M</td>
<td>60.17M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Business First Bancshares <a href="https://www.benzinga.com/quote/BFST/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BFST

Business First Bancshares: Q4 Earnings Insights

<p><strong>East West Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) just disclosed its Q4 earnings on Thursday, January 23, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>East West Bancorp missed estimated earnings by -2.0%, reporting an EPS of $2.08 versus an estimate of $2.12.</p>
<p>Revenue was up $12.79 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company beat on EPS by $0.03 in the last quarter, resulting in a 6.0% increase share price change the following day.</p>
<p>Here's a look at East West Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.06</td>
<td>1.97</td>
<td>2</td>
<td>1.89</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.09</td>
<td>2.07</td>
<td>2.08</td>
<td>2.02</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>561.26M</td>
<td>554.96M</td>
<td>581.10M</td>
<td>576.55M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>572.72M</td>
<td>553.23M</td>
<td>565.14M</td>
<td>574.83M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for East West Bancorp <a href="https://www.benzinga.com/quote/EWBC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


EWBC

East West Bancorp Earnings Report: Q4 Overview

<p><strong>SouthState</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) reported its Q4 earnings results on Thursday, January 23, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>SouthState beat estimated earnings by 12.0%, reporting an EPS of $1.93 versus an estimate of $1.72.</p>
<p>Revenue was up $30.60 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company beat on EPS by $0.26, resulting in a 1.0% increase change in the share price the following day.</p>
<p>Here's a look at SouthState's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.64</td>
<td>1.54</td>
<td>1.55</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.90</td>
<td>1.79</td>
<td>1.58</td>
<td>1.67</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>429.33M</td>
<td>418.08M</td>
<td>414.33M</td>
<td>417.72M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>426.41M</td>
<td>425.48M</td>
<td>415.49M</td>
<td>419.72M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for SouthState <a href="https://www.benzinga.com/quote/SSB/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SouthState Earnings Review: Q4 Summary

<p>The Q4 earnings report for <strong>OceanFirst Financial</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) was released on Thursday, January 23, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>OceanFirst Financial beat estimated earnings by 3.0%, reporting an EPS of $0.38 versus an estimate of $0.37.</p>
<p>Revenue was down $4.50 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>Last quarter the company beat on EPS by $0.01 which was followed by a 2.0% drop in the share price the next day.</p>
<p>Here's a look at OceanFirst Financial's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.38</td>
<td>0.43</td>
<td>0.41</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.39</td>
<td>0.39</td>
<td>0.44</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>83.18M</td>
<td>85.46M</td>
<td>87.40M</td>
<td>90.36M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>82.22M</td>
<td>82.26M</td>
<td>86.22M</td>
<td>87.82M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for OceanFirst Financial <a href="https://www.benzinga.com/quote/OCFC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


OCFC

OceanFirst Financial: Q4 Earnings Insights

<p>NextEra Energy Partners, LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) today announced the company is changing its name to XPLR Infrastructure, LP, effective today, and will begin trading under the new ticker symbol, XIFR, on the New York Stock Exchange (NYSE) on Tuesday, Feb. 3, 2025.</p>


NextEra Energy Partners, LP To Be Renamed XPLR Infrastructure, LP, Effective Today; Will Begin Trading Under The New Ticker Symbol, "XIFR" On The NYSE On Tuesday, Feb. 3, 2025.

<p>The Q4 earnings report for <strong>Byline Bancorp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BY#NYSE">BY</a>) was released on Thursday, January 23, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Byline Bancorp beat estimated earnings by 13.0%, reporting an EPS of $0.69 versus an estimate of $0.61.</p>
<p>Revenue was up $3.88 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.05, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at Byline Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.65</td>
<td>0.63</td>
<td>0.63</td>
<td>0.67</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.70</td>
<td>0.68</td>
<td>0.70</td>
<td>0.73</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>101.08M</td>
<td>99.23M</td>
<td>98.06M</td>
<td>101.40M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>101.84M</td>
<td>99.37M</td>
<td>101.01M</td>
<td>100.79M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Byline Bancorp <a href="https://www.benzinga.com/quote/BY/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Byline Bancorp Q4

<p>The Q4 earnings report for <strong>SB Finl Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) was released on Thursday, January 23, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>SB Finl Gr beat estimated earnings by 27.0%, reporting an EPS of $0.52 versus an estimate of $0.41.</p>
<p>Revenue was up $339 thousand from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company missed on EPS by $0.01 in the last quarter, resulting in a 6.0% drop share price change the following day.</p>
<p>Here's a look at SB Finl Gr's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.42</td>
<td>0.35</td>
<td>0.30</td>
<td>0.35</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.41</td>
<td>0.46</td>
<td>0.33</td>
<td>0.57</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>9.70M</td>
<td>9.40M</td>
<td>9.50M</td>
<td>9.40M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>14.31M</td>
<td>14.04M</td>
<td>13.13M</td>
<td>15.12M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for SB Finl Gr <a href="https://www.benzinga.com/quote/SBFG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SBFG

SB Finl Gr Q4 Earnings Assessment

<p>The Q4 earnings report for <strong>First Bank</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) was released on Thursday, January 23, 2025 at 04:37 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>First Bank beat estimated earnings by 8.0%, reporting an EPS of $0.42 versus an estimate of $0.39.</p>
<p>Revenue was up $5.77 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company missed on EPS by $0.06 in the previous quarter, leading to a 5.0% drop share price change the next day.</p>
<p>Here's a look at First Bank's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.40</td>
<td>0.40</td>
<td>0.42</td>
<td>0.39</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.34</td>
<td>0.47</td>
<td>0.49</td>
<td>0.49</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>31.55M</td>
<td>30.31M</td>
<td>31.41M</td>
<td>29.58M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>32.57M</td>
<td>31.23M</td>
<td>32.28M</td>
<td>28.00M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for First Bank <a href="https://www.benzinga.com/quote/FRBA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FRBA

Earnings Breakdown: First Bank Q4

<p>BayCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCML#NASDAQ">BCML</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.51 by 7.84 percent. This is unchanged from the same period last year.</p>


Earnings Beats

BCML

BayCom Q4 EPS $0.55 Beats $0.51 Estimate

<p><strong>Moderna Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares closed up Thursday gaining momentum following recent comments by Oracle Chairman <strong>Larry Ellison</strong> about the role of artificial intelligence in<a href="https://www.benzinga.com/general/health-care/25/01/43145442/moderna-shares-are-up-today-whats-going-on"> revolutionizing cancer treatment.</a></p>
<p><strong>What To Know: </strong>Ellison, speaking at a White House event, highlighted AI&#8217;s potential to analyze blood tests for early cancer detection, identify tumor fragments and sequence cancer genes to create personalized mRNA vaccines. He claimed AI-driven automation could enable the production of these vaccines within 48 hours, significantly expediting personalized treatment.</p>
<p>The remarks were made as part of the announcement of Stargate, a $500 billion private-sector initiative led by OpenAI, SoftBank and Oracle to develop large-scale AI infrastructure in the U.S. President <strong>Donald Trump </strong>emphasized the project&#8217;s significance in advancing AI capabilities and creating over 100,000 jobs.</p>
<p>The initiative includes the construction of 20 massive data centers, with the first already underway in Texas. These facilities will support AI applications in healthcare, including electronic health record analysis and advanced diagnostics.</p>
<p><strong>MRNA Price Action:</strong> Moderna shares closed Thursday up 10.10% at $42.39, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="527" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-1024x527.png" alt="" class="wp-image-747744" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-1024x527.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-768x395.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45.png 1393w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/specialty-etfs/25/01/43160029/tesla-nvidia-etfs-in-the-works-to-tap-rising-interest-in-same-day-stock-options">Tesla, Nvidia ETFs In The Works To Tap Rising Interest In Same-Day Stock Options</a></strong></li>
</ul>
<p><em>Photo: Shutterstock.</em></p>


Biotech

MRNA

Moderna Shares Are Up Today: What's Going On?

<p>USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) reported quarterly earnings of $0.34 per share which missed the analyst consensus estimate of $0.36 by 5.56 percent. This is a 100 percent increase over earnings of $0.17 per share from the same period last year.  The company reported quarterly sales of $22.98 million which beat the analyst consensus estimate of $22.41 million by 2.57 percent.  This is a 46.38 percent increase over sales of $15.70 million the same period last year.</p>


Earnings Misses

USCB

USCB Financial Holdings Q4 Adj $0.34 Misses $0.36 Estimate, Sales $22.98M Beat $22.41M Estimate

<p>The earnings results for <strong>CSX</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) for Q4 were made public on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>CSX missed estimated earnings by 0.0%, reporting an EPS of $0.42 versus an estimate of $0.42.</p>
<p>Revenue was down $140.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed on EPS by $0.02 which was followed by a 7.000000000000001% drop in the share price the next day.</p>
<p>Here's a look at CSX's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.48</td>
<td>0.48</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.46</td>
<td>0.49</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>3.67B</td>
<td>3.70B</td>
<td>3.66B</td>
<td>3.63B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>3.62B</td>
<td>3.70B</td>
<td>3.68B</td>
<td>3.68B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for CSX <a href="https://www.benzinga.com/quote/CSX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CSX: Q4 Earnings Insights

<p><strong>Business First Bancshares</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) announced its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Business First Bancshares beat estimated earnings by 35.0%, reporting an EPS of $0.66 versus an estimate of $0.49.</p>
<p>Revenue was up $17.41 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.11, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at Business First Bancshares's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.57</td>
<td>0.51</td>
<td>0.57</td>
<td>0.60</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.64</td>
<td>0.50</td>
<td>0.66</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>65.32M</td>
<td>62.96M</td>
<td>62.22M</td>
<td>62.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>66.90M</td>
<td>66.19M</td>
<td>60.92M</td>
<td>60.17M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Business First Bancshares <a href="https://www.benzinga.com/quote/BFST/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Business First Bancshares Q4

Press Releases

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers

Certain BlackRock Funds Announce Final Results of Tender Offers

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs

Comments

BlackRock Science

BlackRock Science (BSTZ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga